Table 1 Characteristics of patients at baseline
Variables | DATT ≤ 1.05 group (N = 24) | DATT > 1.05 group (N = 69) | P value |
|---|---|---|---|
Gender | 0.742 | ||
Male | 18 (75.0%) | 54 (78.3%) | |
Female | 6 (25.0%) | 15 (21.7%) | |
Age, years | 64 (17–83) | 58 (16–81) | 0.563 |
ATT regimens | 0.198 | ||
HRZE | 14 (58.3%) | 50 (72.5%) | |
Other | 10 (41.7%) | 19 (27.5%) | |
Preoperative NYHA functional class | 0.396 | ||
I | 1 (4.2%) | 6 (8.7%) | |
II | 5 (20.8%) | 24 (34.8%) | |
III | 17 (70.8%) | 35 (50.7%) | |
IV | 1 (4.2%) | 4 (5.8%) | |
Hypertension | 2 (8.3%) | 12 (17.4%) | 0.461 |
Diabetes | 3 (12.5%) | 3 (4.3%) | 0.359 |
Atrial fibrillation | 4 (16.7%) | 11 (15.9%) | 1.000 |
HIV infection | 0 (0%) | 0 (0%) | / |
BMI, kg/m2 | 19.7 (14.9–26.6) | 21.1 (16.3–33.1) | 0.057 |
Preoperative CVP, cmH2O | 30.0 (16.0–42.0) | 26.0 (15.5–40.0) | 0.278 |
Pleural effusion | 24 (100.0%) | 63 (91.3%) | 0.312 |
Ascites | 15 (62.5%) | 35 (50.7%) | 0.319 |
Pericardial effusion | 17 (70.8%) | 55 (79.7%) | 0.370 |
Pericardial calcification | 5 (20.8%) | 17 (24.6%) | 0.706 |
Pericardial thickness, mm | 10.9 (5.0–18.9) | 10.0 (3.4–18.9) | 0.148 |
LVEF, % | 60.9 (51.9–78.0) | 57.6 (39.9–74.0) | 0.147 |
Hemoglobin, g/dL | 123 (94–151) | 122 (90–167) | 0.772 |
CRP, mg/L | 19.6 (1.5–99.1) | 16.3 (0.8–78.0) | 0.206 |
ESR, mm/h | 36.5 (7.0–89.0) | 16.5 (2.0–105.0) | 0.008 |
Albumin, g/L | 31.7 (24.8–41.7) | 33.0 (20.3–48.8) | 0.566 |
Total bilirubin, μmol/L | 14.6 (6.4–66.7) | 18.8 (3.1–59.2) | 0.481 |
Direct bilirubin, μmol/L | 8.8 (3.2–36.4) | 11.3 (1.8–50.3) | 0.329 |
Serum creatinine, μmol/L | 85.1 (62.8–116.1) | 81.2 (44.5–120.6) | 0.137 |
Preoperative BNP, pg/mL | 165 (21–961) | 169 (21–786) | 0.575 |